c.i. direct blue 1 has been researched along with Carcinoma, Ductal, Pancreatic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barile, M; Cardone, RA; Carvalho, TMA; Di Molfetta, D; Galluccio, M; Indiveri, C; Leone, P; Medina, M; Nisco, A; Reshkin, SJ; Tolomeo, M | 1 |
1 other study(ies) available for c.i. direct blue 1 and Carcinoma, Ductal, Pancreatic
| Article | Year |
|---|---|
Increased demand for FAD synthesis in differentiated and stem pancreatic cancer cells is accomplished by modulating FLAD1 gene expression: the inhibitory effect of Chicago Sky Blue.
Topics: Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Gene Expression; Humans; Neoplastic Stem Cells; Pancreatic Neoplasms; Tumor Suppressor Protein p53 | 2023 |